Apnea of Prematurity Clinical Trial
Official title:
Effect of Three-Stair-Position on Improvement of Apnea of Prematurity and Feeding Performance in Prematurity: A Randomized Control Trial
Verified date | January 2015 |
Source | Children's Hospital of Fudan University |
Contact | n/a |
Is FDA regulated | No |
Health authority | China: Ministry of Health |
Study type | Interventional |
The purpose of this study is evaluating the effectiveness of three-stair-position (TSP) on the rate of Apnea of Prematurity (AOP), the feeding performance and the vital signs.
Status | Completed |
Enrollment | 144 |
Est. completion date | December 2014 |
Est. primary completion date | August 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A to 3 Days |
Eligibility |
Inclusion Criteria: 1. preterm, gestational age(GA) <34weeks determined by obstetric ultra-sonogram and clinical examination 2. steady vital signs 3. Apgar scores were greater than or equal to 3 at 1min and greater than or equal to 5 at 5 minutes. Exclusion Criteria: 1. infants with congenital malformation,for example Congenital Heart Disease, Diaphragmatic hernia, Hirschsprung,etc 2. Infants who need special position and/or intervention (gastroschisis or umbilical catheterization) 3. weight<1000g 4. infants who were undertaking conventional invasive mechanical ventilation. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Children's Hospital of Fudan University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The rate of AOP | 7 Days | No | |
Primary | Frequency of desaturation which defined as oxygen saturation by pulse oximetry (SPO2)<85% | 7 Days | No | |
Secondary | Number of Participants who need treatments | Treatments of AOP include stimulation, nasal cannula oxygen, pressurized oxygen, continuous positive airway pressure (CPAP), invasive mechanical ventilation, medication (pulmonary surfactant, aminophylline). | 7 Days | No |
Secondary | Adverse events during feeding | 7 Days | Yes | |
Secondary | Times of milk retention | 7 Days | No | |
Secondary | Number of Participants with distension | Distension was diagnosed by a doctor and a nurse. | 7 Days | Yes |
Secondary | Heart rate | 7 Days | No | |
Secondary | Number of Participants with Adverse Events | 7 Days | Yes | |
Secondary | amount of retention milk | 7 Days | No | |
Secondary | respiratory rate | 7 Days | No | |
Secondary | SPO2 | 7 Days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03670732 -
CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure
|
N/A | |
Terminated |
NCT02524249 -
Early Versus Late Caffeine for ELBW Newborns
|
N/A | |
Completed |
NCT03292562 -
A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation
|
N/A | |
Recruiting |
NCT05298748 -
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
|
N/A | |
Recruiting |
NCT05968586 -
Non-Invasive Neurally Adjusted Ventilatory Assist (NAVA) Prone vs Supine in Premature Infants
|
N/A | |
Active, not recruiting |
NCT02641249 -
Non-invasive Intervention for Apnea of Prematurity
|
N/A | |
Terminated |
NCT01911182 -
Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea
|
Phase 2/Phase 3 | |
Completed |
NCT00182312 -
Caffeine for Apnea of Prematurity (CAP)
|
Phase 3 | |
Recruiting |
NCT03651648 -
Apnea Treatment in Premature Infants Using an Automatic Vibro-tactile Stimulator Triggered by the Detection of Apnea-bradycardia.
|
N/A | |
Recruiting |
NCT03298347 -
Caffeine for Preterm Infants With Apnea of Prematurity(AOP)
|
N/A | |
Completed |
NCT01020357 -
Caffeine for Apnea of Prematurity-Sleep (CAP-S) Study
|
Phase 3 | |
Completed |
NCT00809055 -
MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine
|
Phase 4 | |
Completed |
NCT03298035 -
A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants
|
N/A | |
Completed |
NCT03695900 -
Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants
|
N/A | |
Completed |
NCT04327466 -
Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants
|
N/A | |
Not yet recruiting |
NCT06374147 -
"Prapela® SVS Incubator Pad for Apnea of Prematurity
|
N/A | |
Completed |
NCT04868565 -
Target Weaning Oxygen to Determine Cafffeine Duration for AOP
|
Phase 4 | |
Terminated |
NCT00482040 -
Randomized Trial Investigating Four Nasal CPAP Systems in the Management of Apnea of Prematurity
|
N/A | |
Not yet recruiting |
NCT06292299 -
The PARS Study: Paediatric Advanced Respiratory Service Study - An Observational Diagnostic Feasibility Study
|
||
Completed |
NCT05393817 -
Caffeine Citrate Use and Electronic Activity of the Diaphragm (EDI) Changes
|